Nishadil
Signup Signin
Delhi | 25°C (windy)
The Silent Crisis: How Gonorrhea is Slipping Past Our Last-Ditch Drugs

The Silent Crisis: How Gonorrhea is Slipping Past Our Last-Ditch Drugs
Terns Pharmaceuticals Soars: A New Dawn for Tough-to-Treat Leukemia Patients?

Terns Pharmaceuticals Soars: A New Dawn for Tough-to-Treat Leukemia Patients?
Incyte Unveils Game-Changing Myelofibrosis Data at ASH 2025

Incyte Unveils Game-Changing Myelofibrosis Data at ASH 2025
ASH 2025: Glimmers of Hope and Big Strides in Blood Disorders

ASH 2025: Glimmers of Hope and Big Strides in Blood Disorders
A Glimmer of Hope: Syndax's Novel AML Drug Shines Bright at ASH Meeting

A Glimmer of Hope: Syndax's Novel AML Drug Shines Bright at ASH Meeting
The Bittersweet Breakthrough: Gertrude Elion's Pioneering Drug in the Fight Against Childhood Leukemia

The Bittersweet Breakthrough: Gertrude Elion's Pioneering Drug in the Fight Against Childhood Leukemia
Vinay Prasad Sounds the Alarm: Media Missteps and Harvard’s Choices Are Hurting Biotech

Vinay Prasad Sounds the Alarm: Media Missteps and Harvard’s Choices Are Hurting Biotech
The Anticipation Builds: ASH 2025 and the Evolving Landscape of Blood Cancer Therapies

The Anticipation Builds: ASH 2025 and the Evolving Landscape of Blood Cancer Therapies
The Unyielding Riddle of Alzheimer's: Why Progress Feels So Elusive

The Unyielding Riddle of Alzheimer's: Why Progress Feels So Elusive
Malaria's Hidden Strategy: Unmasking the Parasite's Corkscrew Journey Through Our Skin

Malaria's Hidden Strategy: Unmasking the Parasite's Corkscrew Journey Through Our Skin
A Beacon of Hope: Capricor's Cell Therapy Shows Remarkable Heart Improvements in Duchenne Patients

A Beacon of Hope: Capricor's Cell Therapy Shows Remarkable Heart Improvements in Duchenne Patients
Cassava Sciences' Simufilam Trial Faces Fresh FDA Scrutiny

Cassava Sciences' Simufilam Trial Faces Fresh FDA Scrutiny
The Enduring Quest: Semaglutide and the Unyielding Challenge of Alzheimer's

The Enduring Quest: Semaglutide and the Unyielding Challenge of Alzheimer's
Wockhardt's Game-Changer: India's First Homegrown NCE Accepted by USFDA – A New Dawn?

Wockhardt's Game-Changer: India's First Homegrown NCE Accepted by USFDA – A New Dawn?
Regeneron and Tessera Forge Potent Alliance for Next-Generation Gene Editing Therapies

Regeneron and Tessera Forge Potent Alliance for Next-Generation Gene Editing Therapies
The Looming Shadow: Why Our New Plan to Fight Antimicrobial Resistance Needs a Serious Boost

The Looming Shadow: Why Our New Plan to Fight Antimicrobial Resistance Needs a Serious Boost
A New Chapter in Rare Disease Treatment: Omeros and Novo Nordisk Finalize Landmark Zaltenibart Deal

A New Chapter in Rare Disease Treatment: Omeros and Novo Nordisk Finalize Landmark Zaltenibart Deal
A Beacon of Hope: Reviva Pharmaceuticals' Brilaroxazine Achieves Pivotal Milestones in Schizophrenia Treatment

A Beacon of Hope: Reviva Pharmaceuticals' Brilaroxazine Achieves Pivotal Milestones in Schizophrenia Treatment
A New Chapter for Wockhardt? Chairman 'Very Confident' on Novel Antibiotic's USFDA Acceptance

A New Chapter for Wockhardt? Chairman 'Very Confident' on Novel Antibiotic's USFDA Acceptance
AI Drug Discovery Takes a Giant Leap: Iambic Therapeutics Secures $100M

AI Drug Discovery Takes a Giant Leap: Iambic Therapeutics Secures $100M
A New Era for Drug Safety: DiPharma Francis Publishes Groundbreaking Nitrosamine Detection Study

A New Era for Drug Safety: DiPharma Francis Publishes Groundbreaking Nitrosamine Detection Study
The Shifting Tides: Is Animal Testing Nearing Its End?

The Shifting Tides: Is Animal Testing Nearing Its End?
A Vital Step Forward: Sarepta's Duchenne Drug Secures Key Testing Clearance

A Vital Step Forward: Sarepta's Duchenne Drug Secures Key Testing Clearance
Amycretin: Is Novo Nordisk's Oral Wonder Drug the Future of Weight Loss and Diabetes Treatment?

Amycretin: Is Novo Nordisk's Oral Wonder Drug the Future of Weight Loss and Diabetes Treatment?
Novo Nordisk's Alzheimer's Trial Setback: A Closer Look

Novo Nordisk's Alzheimer's Trial Setback: A Closer Look
Tonix Pharmaceuticals Gets the Go-Ahead: TNX-102 Enters Clinical Development for Major Depression

Tonix Pharmaceuticals Gets the Go-Ahead: TNX-102 Enters Clinical Development for Major Depression
The Unfolding Saga of GLP-1 Drugs: A Potential Game-Changer for Alzheimer's?

The Unfolding Saga of GLP-1 Drugs: A Potential Game-Changer for Alzheimer's?
The Trillion-Dollar Bet: How Eli Lilly is Reshaping the Global Economy

The Trillion-Dollar Bet: How Eli Lilly is Reshaping the Global Economy
When Leadership Takes the Reins: Unpacking the FDA's Unusual Priority Voucher Vote

When Leadership Takes the Reins: Unpacking the FDA's Unusual Priority Voucher Vote
The Evolving Landscape of Biotech Innovation and Investment

The Evolving Landscape of Biotech Innovation and Investment
A Glimmer of Hope? Telo Genomics Stock Jumps as Early Study Shows Leukemia Cell Death

A Glimmer of Hope? Telo Genomics Stock Jumps as Early Study Shows Leukemia Cell Death
The Shifting Sands of Biotech M&A: Navigating a New Era with Veteran Insight

The Shifting Sands of Biotech M&A: Navigating a New Era with Veteran Insight
The FDA's Golden Ticket: A Moral Maze in Drug Development

The FDA's Golden Ticket: A Moral Maze in Drug Development
The Human Face of AI: How Recursion Pharma and Najat Khan Are Redefining Drug Discovery

The Human Face of AI: How Recursion Pharma and Najat Khan Are Redefining Drug Discovery
The High-Stakes Gamble: Summit's Vision vs. Akeso's Strategic Play with Ivonesimab

The High-Stakes Gamble: Summit's Vision vs. Akeso's Strategic Play with Ivonesimab
The Rollercoaster Ride of Hope and Dilution: Galmed's Cancer Breakthrough Sends Stock Soaring—But What About the Small Guys?

The Rollercoaster Ride of Hope and Dilution: Galmed's Cancer Breakthrough Sends Stock Soaring—But What About the Small Guys?
The Fibromyalgia Frontier: Why Tonix Pharmaceuticals Just Rocketed into the Spotlight

The Fibromyalgia Frontier: Why Tonix Pharmaceuticals Just Rocketed into the Spotlight
The Tiny Revolution: How IIT-BHU's Nanomedicine Could Transform Life with Inflammatory Illnesses

The Tiny Revolution: How IIT-BHU's Nanomedicine Could Transform Life with Inflammatory Illnesses
The Unseen Hand: WuXi AppTec's Unstoppable Ascent Amidst Global Scrutiny

The Unseen Hand: WuXi AppTec's Unstoppable Ascent Amidst Global Scrutiny
The Unseen Battle: How Komzifti is Redrawing the Lines in Leukemia's Long War

The Unseen Battle: How Komzifti is Redrawing the Lines in Leukemia's Long War
AnaptysBio's Big Bet: Decoding the ANB033 Play in the High-Stakes World of Rheumatoid Arthritis

AnaptysBio's Big Bet: Decoding the ANB033 Play in the High-Stakes World of Rheumatoid Arthritis
The Quiet Revolution: How One Pill Could Change the Game for Sickle Cell and Thalassemia Patients

The Quiet Revolution: How One Pill Could Change the Game for Sickle Cell and Thalassemia Patients
The Quiet Hum of Hope and High Stakes: Unpacking the Future of Huntington's Treatment

The Quiet Hum of Hope and High Stakes: Unpacking the Future of Huntington's Treatment
Load more..